Product Information

LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0517 per EA under NDC 33342020010. Its NADAC has been published 498 times since Feb 8, 2017.

FDA first approved this application on Jan 11, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOCETIRIZINE 5 MG TABLET

LEVOCETIRIZINE DIHYDROCHLORIDE
$0.0517per EA

Strength

5 mg/1

NDC

33342020010

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205564

FDA Approved

1/11/2016

TE Code

AB

On Market Since

1/11/2016

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 498 times since Feb 8, 2017, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0517 per EA
All-time high$0.2097 (May 16, 2018)
All-time low$0.0517 (Aug 19, 2026)
52-week high$0.0590
52-week low$0.0517
Median price$0.0765
Average price$0.0839
Largest weekly change+51.3% (Apr 18, 2018)
Weeks tracked498
Tracking sinceFeb 8, 2017

Price History

1W

-0.2%

1M

-0.2%

3M

-4.7%

6M

-6.1%

1Y

-12.3%

3Y

-32.4%

5Y

-26.7%

All

-61.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOCETIRIZINE DIHYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0517 per EA (NDC 33342020010), effective Aug 19, 2026.

How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 61.9%. It has been tracked across 498 weekly CMS publications since Feb 8, 2017.

What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?

Since Feb 8, 2017, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.0517 (Aug 19, 2026) to a high of $0.2097 (May 16, 2018), with a median of $0.0765 per EA.

Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LEVOCETIRIZINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LEVOCETIRIZINE 5 MG TABLET?

LEVOCETIRIZINE 5 MG TABLET (NDC 33342020010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.